141 related articles for article (PubMed ID: 36675827)
21. Evaluation of the Performance of the Associates of Cape Cod STAT Assay for the Diagnosis of Invasive Fungal Disease in Critical-Care Patients with COVID-19.
White PL; Price JS; Backx M
J Clin Microbiol; 2021 Aug; 59(9):e0086921. PubMed ID: 34190576
[TBL] [Abstract][Full Text] [Related]
22. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
[TBL] [Abstract][Full Text] [Related]
23. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
[TBL] [Abstract][Full Text] [Related]
24. Combination of serum and peritoneal 1.3-beta-D-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study.
Novy E; Rivière J; Nguyen M; Arfeuille G; Louis G; Bouhemad B; Pottecher J; Hecketsweiler S; Germain A; Laithier FX; Losser MR; Debourgogne A; Bernard Y; Rousseau H; Baumann C; Luc A; Birckener J; Machouart MC; Guerci P
Crit Care; 2023 Nov; 27(1):470. PubMed ID: 38037130
[TBL] [Abstract][Full Text] [Related]
25. Comparison between Wako-WB003 and Fungitec G tests for detection of (1-->3)-beta-D-glucan in systemic mycosis.
Hossain MA; Miyazaki T; Mitsutake K; Kakeya H; Yamamoto Y; Yanagihara K; Kawamura S; Otsubo T; Hirakata Y; Tashiro T; Kohno S
J Clin Lab Anal; 1997; 11(2):73-7. PubMed ID: 9058239
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the Dynamiker
Siopi M; Karakatsanis S; Roumpakis C; Korantanis K; Eldeik E; Sambatakou H; Sipsas NV; Pagoni M; Stamouli M; Tsirigotis P; Meletiadis J
Infect Dis Ther; 2022 Jun; 11(3):1161-1175. PubMed ID: 35404009
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
[TBL] [Abstract][Full Text] [Related]
28. [The performance of (1, 3)-beta-D-glucan and Aspergillus galactomannan measurement for early diagnosis of invasive aspergillosis in patients with hematological diseases].
Horiguchi Y
Kansenshogaku Zasshi; 2004 Jul; 78(7):566-73. PubMed ID: 15359888
[TBL] [Abstract][Full Text] [Related]
29. Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases.
Angebault C; Lanternier F; Dalle F; Schrimpf C; Roupie AL; Dupuis A; Agathine A; Scemla A; Paubelle E; Caillot D; Neven B; Frange P; Suarez F; d'Enfert C; Lortholary O; Bougnoux ME
Open Forum Infect Dis; 2016 Sep; 3(3):ofw128. PubMed ID: 27419189
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
31. Prospective Evaluation of the Turbidimetric β-D-Glucan Assay and 2 Lateral Flow Assays on Serum in Invasive Aspergillosis.
Mercier T; Guldentops E; Lagrou K; Maertens J
Clin Infect Dis; 2021 May; 72(9):1577-1584. PubMed ID: 32188971
[TBL] [Abstract][Full Text] [Related]
32. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
[TBL] [Abstract][Full Text] [Related]
33. Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.
Giacobbe DR; Del Bono V; Viscoli C; Mikulska M
Expert Rev Anti Infect Ther; 2017 Dec; 15(12):1101-1112. PubMed ID: 29125373
[TBL] [Abstract][Full Text] [Related]
34. Role of (1-3)-Β-D-Glucan Test in the Diagnosis of Invasive Fungal Infections among High-Risk Patients in a Tertiary Care Hospital.
Sandhar TK; Chhina DK; Gupta V; Chaudhary J
J Lab Physicians; 2022 Sep; 14(3):306-311. PubMed ID: 36119434
[No Abstract] [Full Text] [Related]
35. UTILITY OF OCULAR β- d -GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITIS.
Xia T; Finkelman M; Kolomeyer A; Ying GS; Bracha P; Miller CG; Elnahry AG; Carroll R; Zhang Y; Saluadades A; Brucker AJ; Kim BJ
Retin Cases Brief Rep; 2023 Nov; 17(6):676-682. PubMed ID: 35199648
[TBL] [Abstract][Full Text] [Related]
36. Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children.
Calitri C; Caviglia I; Cangemi G; Furfaro E; Bandettini R; Fioredda F; Amoroso L; Faraci M; Risso FM; Mattioli G; Moscatelli A; Haupt R; Castagnola E
Mycoses; 2017 Dec; 60(12):789-795. PubMed ID: 28833726
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of invasive fungal disease in hospitalized patients with chronic obstructive pulmonary disease.
Mohedano Del Pozo RB; Rubio Alonso M; Cuétara García MS
Rev Iberoam Micol; 2018; 35(3):117-122. PubMed ID: 30078525
[TBL] [Abstract][Full Text] [Related]
38. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.
Nguyen MH; Wissel MC; Shields RK; Salomoni MA; Hao B; Press EG; Shields RM; Cheng S; Mitsani D; Vadnerkar A; Silveira FP; Kleiboeker SB; Clancy CJ
Clin Infect Dis; 2012 May; 54(9):1240-8. PubMed ID: 22431804
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
[TBL] [Abstract][Full Text] [Related]
40. β-D-Glucan Screening for Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Koltze A; Rath P; Schöning S; Steinmann J; Wichelhaus TA; Bader P; Bochennek K; Lehrnbecher T
J Clin Microbiol; 2015 Aug; 53(8):2605-10. PubMed ID: 26041896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
